Direct comparison
DMEM vs RPMI 1640: Buying Guide
Compare DMEM and RPMI 1640 media on formulation, cell-type fit, and the documentation to request when procuring either for a lab program.
Written and maintained by CASRAI Editorial Board
Last updated
Ask CASRAI · included with Regulatory Radar
Ask about DMEM vs RPMI 1640: Buying Guide
Ask CASRAI answers research-administration questions and cites the passages behind every claim — and says so when the corpus does not cover something, instead of guessing. It comes with a Regulatory Radar subscription at $29 a month, alongside the daily digest of regulatory changes and the dashboard of what changed.
150 questions a day, on this site, over the API, or inside your own tools through the CASRAI MCP server.
Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays free to read, with no account and no card.
How do DMEM, RPMI 1640 compare side by side?
The table below compares DMEM, RPMI 1640 across 8 procurement-relevant dimensions, from developed for through interchangeable mid-study?.
Side-by-side comparison
| Dimension | DMEM | RPMI 1640 |
|---|---|---|
| Developed for | Modification of Eagle’s MEM by Renato Dulbecco; broad adherent-cell use | Developed at Roswell Park Memorial Institute for human leukemic/lymphoid cells |
| Typical cell types | Adherent fibroblast/epithelial lines (HeLa, HEK293, CHO, and many others) | Lymphocytes, hybridomas, other hematopoietic/immune and suspension lines |
| Glucose concentration | High-glucose (~4.5 g/L) or low-glucose (~1 g/L) variants available | Single lower-glucose formulation (~2 g/L), closer to physiological blood glucose |
| Distinct extra components | Higher overall amino acid/vitamin concentration than base Eagle’s MEM | Reduced glutathione, biotin, vitamin B12, PABA not present in DMEM |
| Buffering options | Bicarbonate-buffered (CO₂ incubator) or HEPES-buffered variants, by catalog number | Bicarbonate-buffered (CO₂ incubator) or HEPES-buffered variants, by catalog number |
| L-glutamine / phenol red | Available with stabilized glutamine or without; with or without phenol red | Available with stabilized glutamine or without; with or without phenol red |
| GMP-grade availability | Available from major suppliers with USP <1043>/Ph. Eur. 5.2.12-aligned documentation | Available from major suppliers with USP <1043>/Ph. Eur. 5.2.12-aligned documentation |
| Interchangeable mid-study? | No — switching requires revalidation of growth/expression endpoints | No — switching requires revalidation of growth/expression endpoints |
Common questions
Common questions about DMEM vs RPMI 1640
Is RPMI 1640 the same as RPMI?
+
Yes, in current commercial catalogs. RPMI 1640 is the standard, current formulation name; the original 1960s formulation was RPMI 1630. Suppliers use "RPMI" and "RPMI 1640" interchangeably today.
Can I substitute DMEM for RPMI 1640 (or vice versa) mid-study?
+
Not without revalidation. The two media differ in glucose concentration, amino acid and vitamin load, and several minor components, and switching can measurably shift growth rate, morphology, and gene/protein expression. Treat a media change as a raw-material change requiring qualification, the same as any other critical reagent substitution.
Is one of these media more expensive to procure than the other?
+
Base catalog pricing for standard-grade DMEM and RPMI 1640 from major suppliers is generally comparable; cost differences in practice come from the grade tier (research vs. GMP-grade with full ancillary-material documentation), format (powder vs. liquid, package size), and glutamine/HEPES variant selected, not from the base formulation itself.
Do both require a CO₂ incubator?
+
Only the bicarbonate-buffered variants do. Both DMEM and RPMI 1640 are available in HEPES-buffered formulations designed for open-bench or CO₂-independent use — check the specific catalog number rather than assuming based on the media name.
What documentation should I request for GMP-grade DMEM or RPMI 1640?
+
For use as an ancillary material in cell, gene, or tissue-engineered product manufacturing, request a lot-specific certificate of analysis, sterility/mycoplasma/endotoxin testing results, animal-origin sourcing statements (including TSE/BSE status for any animal-derived components), change-notification commitments, and evidence of the supplier’s quality-management system — consistent with USP <1043>, Ph. Eur. 5.2.12, and the ISO 20399 ancillary-materials series.
